We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 3,314 results
  1. Brain Endothelial Cells: Metabolic Flux and Energy Metabolism

    The neurovascular unit (NVU) consists of multiple cell types including brain endothelial cells, pericytes, astrocytes, and neurons that function...
    Cade J. McDonald, Zachery J. Blankenheim, Lester R. Drewes in Physiology, Pharmacology and Pathology of the Blood-Brain Barrier
    Chapter 2021
  2. Human Blood-Brain-Barrier In Vitro Models: Overview and Applications

    The human blood-brain-barrier (BBB) is a vital structure for brain health. Conversely it represents a challenge in drug development programmes that...
    Chapter 2021
  3. Interaction of Bovine Lymphocytes with Products of Shiga Toxin-Producing Escherichia coli

    Shiga toxin-producing Escherichia coli (STEC) produce a number of virulence factors that interfere with lymphocyte functions, including mitogen- and...
    Andrew G. Bease, Robin L. Cassady-Cain, Mark P. Stevens in Shiga Toxin-Producing E. coli
    Protocol 2021
  4. Thin-Layer Chromatography in Structure and Recognition Studies of Shiga Toxin Glycosphingolipid Receptors

    Glycosphingolipids (GSLs) consist of a ceramide (Cer) lipid anchor, which is typically composed of the long-chain aminoalcohol sphingosine (d18:1)...
    Johanna Detzner, Gottfried Pohlentz, Johannes Müthing in Shiga Toxin-Producing E. coli
    Protocol 2021
  5. Citrobacter rodentium Lysogenized with a Shiga Toxin-Producing Phage: A Murine Model for Shiga Toxin-Producing E. coli Infection

    Shiga toxin-producing E. coli (STEC) is a common foodborne pathogen in developed countries. STEC generates “attaching and effacing” (AE) lesions on...
    Laurice J. Flowers, Shenglan Hu, ... Marcia S. Osburne in Shiga Toxin-Producing E. coli
    Protocol 2021
  6. Use of the Dynamic TIM-1 Model for an In-Depth Understanding of the Survival and Virulence Gene Expression of Shiga Toxin-Producing Escherichia coli in the Human Stomach and Small Intestine

    Due to obvious ethical and technical reasons, it remains very difficult to evaluate the survival and expression of virulence genes of food-borne...
    Ophélie Uriot, Sandrine Chalancon, ... Stéphanie Blanquet-Diot in Shiga Toxin-Producing E. coli
    Protocol 2021
  7. Determining Shiga Toxin-Producing Escherichia coli Interactions with Human Intestinal Epithelium in a Microaerobic Vertical Diffusion Chamber

    The environment in the human intestine is low in oxygen. This affects virulence gene expression of enteropathogens including Shiga toxin-producing E....
    Conor J. McGrath, Stephanie Schüller in Shiga Toxin-Producing E. coli
    Protocol 2021
  8. Measuring Effector-Mediated Modulation of Inflammatory Responses to Infection with Enteropathogenic and Shiga Toxin-Producing E. coli

    Shiga toxin-producing Escherichia coli (STEC) and the related pathogen enteropathogenic Escherichia coli (EPEC) use a type III secretion system to...
    Georgina L. Pollock, Cristina Giogha, Elizabeth L. Hartland in Shiga Toxin-Producing E. coli
    Protocol 2021
  9. Overview of the Effect of Citrobacter rodentium Infection on Host Metabolism and the Microbiota

    Citrobacter rodentium is a natural enteric mouse pathogen that models human intestinal diseases, such as pathogenic E. coli infections, ulcerative...
    Eve G. D. Hopkins, Gad Frankel in Shiga Toxin-Producing E. coli
    Protocol 2021
  10. Predicting Host Association for Shiga Toxin-Producing E. coli Serogroups by Machine Learning

    Escherichia coli is a species of bacteria that can be present in a wide variety of mammalian hosts and potentially soil environments. E. coli has an...
    Nadejda Lupolova, Antonia Chalka, David L. Gally in Shiga Toxin-Producing E. coli
    Protocol 2021
  11. Infection of Immunocompetent Conventional Mice with Shiga Toxin-Producing E. coli: The DSS + STEC Model

    Previous methods of infecting mice with Shiga toxin-producing E. coli (STEC) required suppression of host immune function or ablation of the gut...
    Gregory Hall, Shinichiro Kurosawa, D. J. Stearns-Kurosawa in Shiga Toxin-Producing E. coli
    Protocol 2021
  12. Functional Analysis of Shiga Toxin-Producing Escherichia coli Biofilm Components in Plant Leaves

    Plants represent alternative or secondary hosts for Shiga toxin-producing Escherichia coli (STEC), enabling transmission of the pathogens through the...
    Nicola J. Holden, Kathryn M. Wright, ... Ashleigh Holmes in Shiga Toxin-Producing E. coli
    Protocol 2021
  13. Detection of Blood Cell Surface Biomarkers in Septic Mice

    Sepsis arises when an infection induces a dysregulated immune response, resulting in organ damage. New methods are urgently needed to diagnose...
    Dinesh G. Goswami, Wendy E. Walker in Sepsis
    Protocol 2021
  14. Induction of Sepsis Via Fibrin Clot Implantation

    Implantation of bacteria embedded in a fibrin clot allows for successful establishment of sepsis in preclinical models. This model allows the...
    Sailaja Ghanta, Min-Young Kwon, Mark A. Perrella in Sepsis
    Protocol 2021
  15. Measurement of Intestinal Permeability During Sepsis

    Gut barrier function has been hypothesized to play a critical role in the pathophysiology of sepsis. Measuring intestinal permeability allows for a...
    Takehiko Oami, Craig M. Coopersmith in Sepsis
    Protocol 2021
  16. Sepsis Biomarkers

    Biomarkers have been used in sepsis to assist with the diagnosis of disease as well as determining the severity of disease, that is, prognosis. These...
    Yachana Kataria, Daniel Remick in Sepsis
    Protocol 2021
  17. Agent-Based Modeling of Systemic Inflammation: A Pathway Toward Controlling Sepsis

    Despite nearly 50 years of research there currently remains no mediator-directed therapy approved for the treatment of sepsis. The failure to...
    Gary An, R. Chase Cockrell in Sepsis
    Protocol 2021
  18. A Mouse Model of Necrotizing Enterocolitis

    Necrotizing enterocolitis (NEC) is an acute inflammatory disease that unforeseeably develops in very low birth weight premature infants. NEC is...
    Belgacem Mihi, Wyatt E. Lanik, ... Misty Good in Sepsis
    Protocol 2021
  19. Francisella tularensis Infection of Mice as a Model of Sepsis

    Sepsis results from the dysregulated immune response to infection. While the stimulator and progression of the septic response is poorly understood,...
    Charles T. Spencer, Mireya G. Ramos Muniz, ... Michelle A. Sanchez Guillen in Sepsis
    Protocol 2021
  20. Skin Disease Models In Vitro and Inflammatory Mechanisms: Predictability for Drug Development

    Investigative skin biology, analysis of human skin diseases, and numerous clinical and pharmaceutical applications rely on skin models characterized...
    Hans Christian Hennies, Yves Poumay in Organotypic Models in Drug Development
    Chapter 2021
Did you find what you were looking for? Share feedback.